Takeda Pharmaceutical Company Limited
Earnings Date & Report
Last updated:
Takeda Pharmaceutical Company Limited’s last earnings date was on 10 May 2023.
Takeda Pharmaceutical Company Limited stock Earnings report, Estimates & History
| 2019-02-01 | 0.75 | 0.75 |
|---|---|---|
| 2019-05-14 | 0.13 | 0.13 |
| 2019-07-31 | 0.56 | 0.56 |
| 2019-11-13 | 0.59 | 0.59 |
| 2020-02-04 | 5.88 | 3 |
| 2020-05-13 | 0.55 | 0.55 |
| 2020-07-31 | 46.2 | 26.47 |
| 2020-11-02 | 2.19 | 1.1 |
| 2021-02-04 | 0.56 | 0.56 |
| 2021-05-11 | 0.41 | 0.41 |
| 2021-07-30 | 0.51 | 0.51 |
| 2021-10-28 | 0.45 | 0.45 |
| 2022-02-03 | 0.54 | 0.54 |
| 2022-05-11 | 0.38 | 0.38 |
| 2022-07-28 | 0.56 | 0.56 |
| 2022-10-27 | 0.52 | 0.52 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Takeda Pharmaceutical Company Limited stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 10 May 2023 | N/A | N/A | N/A | N/A | N/A | |
| 2 Feb 2023 | N/A | N/A | $0.46 | N/A | 1.09T | |
| 31 Dec 2022 | N/A | N/A | $37.82 | N/A | 1.09T | |
| 27 Oct 2022 | Matched | $0.52 | $0.52 | N/A | 1.00T | |
| 28 Jul 2022 | Matched | $0.56 | $0.56 | 7.49M | 972.46B | |
| 11 May 2022 | Matched | $0.38 | $0.38 | 7.49M | 873.28B | Earnings Call Transcript |
| 3 Feb 2022 | Matched | $0.54 | $0.54 | 7.49M | 901.29B | Earnings Call Transcript |
| 28 Oct 2021 | Matched | $0.45 | $0.45 | 7.49M | 844.82B | Earnings Call Transcript |
| 30 Jul 2021 | Matched | $0.51 | $0.51 | 7.49M | 949.60B | Earnings Call Transcript |
| 11 May 2021 | Matched | $0.41 | $0.41 | N/A | 770.27B | Earnings Call Transcript |
| 4 Feb 2021 | Matched | $0.56 | $0.56 | N/A | 836.75B | Earnings Call Transcript |
| 2 Nov 2020 | Missed | $2.19 | $1.1 | 1.41T | 788.93B | |
| 31 Jul 2020 | Missed | $46.2 | $26.47 | 3.15T | 801.85B | Earnings Call Transcript |
| 13 May 2020 | Matched | $0.55 | $0.55 | N/A | 771.70B | |
| 4 Feb 2020 | Missed | $5.88 | $3 | 1.51T | 859.31B | |
| 13 Nov 2019 | Matched | $0.59 | $0.59 | N/A | 811.04B | |
| 31 Jul 2019 | Matched | $0.56 | $0.56 | N/A | 849.12B | |
| 14 May 2019 | Matched | $0.13 | $0.13 | N/A | 717.21B | |
| 1 Feb 2019 | Matched | $0.75 | $0.75 | N/A | 499.40B | |
| 31 Oct 2018 | N/A | N/A | $30.74 | N/A | 430.77B | |
Takeda Pharmaceutical Company Limited Earnings report FAQs
When is Takeda Pharmaceutical Company Limited's next Earnings date?
The company has not set the next earnings date yet. The latest Takeda Pharmaceutical Company Limited's earnings date was on 28 Jul 2022.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.